Long-term kappa-carrageenan consumption leads to moderate metabolic disorder by blocking insulin binding
- 2 January 2021
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 165, 105417
- https://doi.org/10.1016/j.phrs.2020.105417
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China-Nuclear Technology Innovation Joint Fund
- National Natural Science Foundation of China-Zhejiang Joint Fund for the Integration of Industrialization and Informatization
- National Key Research and Development Program of China
This publication has 39 references indexed in Scilit:
- Carrageenan-Induced Colonic Inflammation Is Reduced in Bcl10 Null Mice and Increased in IL-10-Deficient MiceMediators of Inflammation, 2013
- Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenansCarbohydrate Polymers, 2010
- Current Availability and Consumption of Carrageenan-Containing FoodsEcology of Food and Nutrition, 2003
- A Critical Review of the Toxicological Effects of Carrageenan and Processed Eucheuma Seaweed on the Gastrointestinal TractCritical Reviews in Toxicology, 2002
- Review of harmful gastrointestinal effects of carrageenan in animal experiments.Environmental Health Perspectives, 2001
- Carrageenans from chilean samples of Stenogramme interrupta (Phyllophoraceae): structural analysis and biological activityPhytochemistry, 2000
- Intestinal uptake and immunological effects of carrageenan—current conceptsFood Additives & Contaminants, 1989
- DANGER OF CARRAGEENAN IN FOODS AND SLIMMING RECIPESThe Lancet, 1981
- Standardization of definition, classification, and reporting in diabetes-related epidemiologic studiesDiabetes Care, 1979
- Carrageenan-induced ulceration of the large intestine in the guinea pigGut, 1971